MedTrace Logo

A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment

NCT01416584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2017-12-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effectiveness of the Therapeutic Workplace in promoting methadone treatment and increasing abstinence in unemployed, out-of-treatment injection heroine users.

Conditions

  • Opiate Dependence

Interventions

BEHAVIORAL

methadone contingency

Participants had to enroll in methadone treatment and take daily doses of methadone to gain access to the workplace.

BEHAVIORAL

Methadone & Abstinence Contingency

Participants had to enroll in methadone treatment and take daily doses of methadone to gain access to the workplace and they had to provide opiate and cocaine negative urine samples to maintain the maximum pay.

Sponsors & Collaborators

Principal Investigators

  • Kenneth Silverman, Ph.D. · Professor, Johns Hopkins University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2013-10-31
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416584 on ClinicalTrials.gov